Healthcare
LIXTE Biotechnology Advances LB-100 Pipeline and Expands Proton Therapy Operations
LIXTE Biotechnology reports first-quarter progress with its lead cancer drug LB-100 moving into expanded ovarian cancer trials and growth at its Liora Technologies subsidiary, signaling strategic expansion in oncology.
MindBio Therapeutics Highlights AI Voice Analysis for Noninvasive Intoxication Detection
MindBio Therapeutics Corp. is advancing AI-powered voice analysis to rapidly detect drug and alcohol intoxication, with potential applications in safety-critical industries like mining, aviation, and law enforcement.
Annovis Bio Achieves 85% Enrollment in Phase 3 Alzheimer’s Trial, Advances Parkinson’s Program
Annovis Bio reports first-quarter progress with 85% enrollment in its pivotal Phase 3 Alzheimer's trial and 40% enrollment in its Parkinson's open-label study, signaling potential regulatory milestones for buntanetap.
NanoViricides Advances Broad-Spectrum Antiviral NV-387 Toward Phase II Trials for MPox in DRC
NanoViricides' quarterly report details progress with NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orphan drug designation for measles, highlighting its broad-spectrum antiviral strategy.
Lantern Pharma Raises $4.4 Million in Registered Direct Offering to Advance AI-Driven Cancer Drug Development
Lantern Pharma has closed a $4.4 million registered direct offering, providing capital to support its AI-powered oncology pipeline and commercial launch of the Zeta.ai platform.
Stonegate Initiates Coverage on StimCell Energetics, Highlighting eBalance Device Potential
Stonegate Capital Partners has initiated coverage on StimCell Energetics Inc., focusing on its single-product eBalance platform and the upcoming home-use redesign, with early data suggesting promise but requiring further validation.
LogicMark's AI-Driven Care Platform Shifts Focus from Reactive to Predictive Safety for Aging Population
LogicMark Inc. evolves personal emergency response systems with AI-powered predictive analytics and blockchain-secured data, addressing the growing demand for independent aging among older adults.
Keona Health Analysis Highlights Standardization as Key to Healthcare Call Center Efficiency
Keona Health's new analysis introduces the Rule of ONE framework, arguing that fragmented workflows, not staff skill, drive inefficiency in healthcare call centers, and that standardization can improve performance metrics.
Leeds Clinic Wins Dental Practice of the Year for Seven-Day Emergency Access
Clarendon Dental Spa in Leeds has been named Dental Practice of the Year at the My Local Awards 2026 Yorkshire, highlighting its seven-day emergency dental care until 10pm and free onsite parking, setting it apart in the region.
Memory Care Specialist Releases Puzzle Books to Help Families Navigate Senior Housing Decisions
Wendy Schabilion, a PAC-certified memory care specialist, publishes two practical guides for families facing the emotional and complex task of choosing senior housing options, drawing on 14 years of clinical experience.
Pensacola Dentist Merges Hyperbaric and Metabolic Therapy with Dental Care to Treat Systemic Health
Biodental Health and Longevity has expanded its services to include hyperbaric oxygen therapy and PNOE metabolic breath analysis, integrating systemic wellness with dental care to address the connection between oral health and chronic disease.
Lucent Psych Expands Telepsychiatry Services to Seattle and Texas, Improving Mental Health Access
Lucent Psych expands online psychiatry to Seattle, WA, and Round Rock, Cedar Park, and Cypress, TX, aiming to increase access for conditions like ADHD, anxiety, depression, and PTSD.
Sioux Falls Oral Surgery Practice Publishes Guide to Ease Patient Anxiety About Tooth Extraction
A new patient education resource from Siouxland Oral & Maxillofacial Surgery aims to demystify tooth extraction procedures, addressing common fears and promoting timely treatment.
Shannon Orthodontics Expands Bilingual Care at Two Florida Locations
Shannon Orthodontics now offers bilingual English and Spanish services at its Davenport and Kissimmee offices, improving access to orthodontic care for Central Florida's growing Spanish-speaking population.
Spanish Fort Pediatric Dentist Expands Access to Exams, Sedation, and Special Needs Care
Malbis Parkway Pediatric Dentistry now accepts new patients in Spanish Fort, Alabama, offering child-focused dental exams, sedation options, and specialized care for children with special needs to meet the needs of the growing Eastern Shore community.
GeoVax Advances GEO-MVA Phase 3 Trial as Mpox Vaccine Supply Concerns Persist
GeoVax reports first quarter 2026 financial results and details plans for a pivotal Phase 3 immunobridging study of its MVA-based mpox/smallpox vaccine, highlighting the strategic importance of diversifying orthopoxvirus vaccine supply amid global supply constraints.
BioStem Technologies Posts Q1 2026 Revenue of $6.1M Amid Strategic Shift to Hospital Market
BioStem Technologies reported a net loss for Q1 2026 as it integrates BioTissue assets and pivots to hospital sales, with revenue declining from prior quarters but expecting sequential growth in H2 2026.
HeartBeam Narrows Loss, Advances Commercial Launch of Cardiac Monitoring Platform
HeartBeam reported a narrower net loss in Q1 2026 as it launched commercial partnerships in key U.S. markets for its FDA-cleared 3D ECG platform, which could transform cardiac care outside medical facilities.
Carmed Pharmaceuticals Launches on OneLavi.com as U.S. Expansion Continues
Carmed Pharmaceuticals, a Turkey-based company specializing in standardized carvacrol-based formulations, expands its U.S. presence by launching select products on OneLavi.com, a curated wellness marketplace.
Dogwood Therapeutics Advances Non-Opioid Pain Pipeline with Phase 2b Data Expected This Fall
Dogwood Therapeutics reported first quarter 2026 financial results, highlighting progress in its non-opioid pain treatments Halneuron and SP16, with key clinical milestones expected in 2026.
Proposed Easing of AI Healthcare Safeguards Sparks Debate
The Department of Health and Human Services' health IT office plans to relax safeguards for AI healthcare tools, drawing mixed reactions and raising concerns about removing real-world testing requirements.
MindBio Therapeutics’ AI Voice Analysis Platform Targets Real-Time Intoxication Detection Market
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, addressing growing demand for noninvasive, scalable solutions in healthcare, workplace safety, and public health.
CNS Pharmaceuticals Reports Q1 2026 Results, Advances Shift to Acquisition-Driven Growth
CNS Pharmaceuticals reported first-quarter 2026 financial results and outlined its strategic transformation toward an acquisition-driven model focused on neurology and oncology, supported by a $22.5 million private placement.
Kairos Pharma Receives 2026 Healthcare Innovation Award for Drug Resistance Research
Kairos Pharma has been recognized with the 2026 GHP Magazine Healthcare & Pharmaceutical Award as the USA leader in drug resistance development, highlighting its work on cancer therapeutics that address treatment resistance.
SureNano Science Featured in BioMedWire Editorial Highlighting GLP-1 Innovation
SureNano Science Ltd. was featured in a BioMedWire editorial discussing its subsidiary GlucaPharm Inc. and its GEP-44 triple agonist peptide, which aims to improve obesity and diabetes treatment with better tolerability and potential non-injectable delivery.
Tonix Pharmaceuticals to Present Real-World Data on Fibromyalgia Treatment at ISPOR 2026
Tonix Pharmaceuticals will present findings from a retrospective cohort study on fibromyalgia treatment patterns using U.S. claims data, offering insights into real-world usage following the launch of its newly approved drug TONMYA.
HeartBeam Advances Commercial Launch, Reports Improved Q1 2026 Results
HeartBeam reported first-quarter 2026 results highlighting initial commercial partnerships in key U.S. markets and an $11.5 million public offering, as it advances its FDA-cleared 3D ECG platform for heart attack detection and ambulatory monitoring.
Oncotelic Therapeutics Featured in Editorial Highlighting Intranasal Drug Delivery for Alzheimer's and Biodefense
Oncotelic Therapeutics' intranasal nose-to-brain delivery platform, featured in a BioMedWire editorial, addresses key challenges in CNS drug delivery for Alzheimer's disease and biodefense research by bypassing the blood-brain barrier.
Testosterone Levels Linked to Glioblastoma Survival in Men, NIH-Funded Study Finds
A new NIH-funded preclinical study reveals that men with higher testosterone levels may have longer survival when diagnosed with glioblastoma, opening potential implications for treatments and companies like CNS Pharmaceuticals.
SureNano Science Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
SureNano Science Ltd. and its subsidiary GlucaPharm Inc. are highlighted for developing GEP-44, a novel triple agonist peptide targeting the expanding GLP-1 market for obesity and metabolic disorders.